Having Trouble Affording Your Lilly Medicine? Contact Us | Learn About Lilly's Global COVID-19 Response

Current Medicines

For more than 140 years, we have worked tirelessly to develop and deliver trusted medicines and diagnostics that meet real needs. Our growing portfolio of medicines includes treatments in the areas of bone muscle joint, cancer, cardiovascular, diabetes, endocrine, immunology, neurodegeneration, neuroscience, and pain.

The product information on this website is intended for residents of the United States.

Commonly Prescribed Medications
Diabetes	Prescribing Information	Medication Guide Instructions for Use - 0.75 mg/0.5 mL Instructions for Use - 1.5 mg/0.5 mL Instructions for Use - 3.0 mg/0.5 mL Instructions for Use - 4.5 mg/0.5 mL
Immunology	Prescribing Information	Medication Guide Instructions for Use – Autoinjector Instructions for Use – Prefilled Syringe
Diabetes	Prescribing Information	Patient Package Insert Instructions for Use – Vial Instructions for Use - KwikPen® Instructions for Use - Luxura HD
Neuroscience	Prescribing Information	Patient Package Insert Instructions for Use – Pen Instructions for Use – Prefilled Syringe
Diabetes	Prescribing Information	Patient Package Insert Instructions for Use – Vial
Diabetes	Prescribing Information	Patient Package Insert Instructions for Use - KwikPen®
Cancer	Prescribing Information	Patient Package Insert
Cancer	Prescribing Information
Immunology	Prescribing Information	Medication Guide
Obesity	Prescribing Information	Medication Guide

If you are a customer and have questions regarding Lilly medicines, please call The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979).

Glyxambi, Jardiance, Jentadueto, Jentadueto XR, Synjardy, Synjardy XR, Tradjenta and Trijardy XR are registered trademarks of Boehringer Ingelheim International GmbH and are used under license.

Basaglar, Glyxambi, Jardiance, Jentadueto, Jentadueto XR, Synjardy, Synjardy XR, Tradjenta and Trijardy XR are part of the Boehringer Ingelheim–Lilly Alliance.